Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis

Imatinib is the therapeutic standard for newly diagnosed patients with chronic myeloid leukemia (CML). In these patients, imatinib has been shown to induce an apoptotic response specifically in cells expressing the oncogenic fusion protein BCR-ABL. Previous studies in our lab revealed that imatinib-...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, JING, XIAO, YUN, XIONG, HUO-MEI, LI, JING, HUANG, BO, ZHANG, HAI-BIN, FENG, DAN-QIN, CHEN, XI-MIN, WANG, XIAO-ZHONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577368/
https://www.ncbi.nlm.nih.gov/pubmed/22211240
http://dx.doi.org/10.3892/ijmm.2011.872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577368/
https://www.ncbi.nlm.nih.gov/pubmed/22211240
http://dx.doi.org/10.3892/ijmm.2011.872

Ejemplares similares